None
Quote | Hancock Jaffe Laboratories Inc. Warrants (NASDAQ:HJLIW)
Last: | $0.56 |
---|---|
Change Percent: | 13.41% |
Open: | $0.52 |
Close: | $0.56 |
High: | $0.5663 |
Low: | $0.52 |
Volume: | 10,292 |
Last Trade Date Time: | 09/30/2021 04:56:19 pm |
News | Hancock Jaffe Laboratories Inc. Warrants (NASDAQ:HJLIW)
Patient Shows Significant Improvement at One Year IRVINE, CA / ACCESSWIRE / December 1, 2020 / Hancock Jaffe Laboratories, Inc. (NASDAQ:HJLI, HJLIW), a developer of medical devices that restore cardiac and vascular health, announced today that the tenth VenoValve patient in HJLI's fi...
Patient Continues to Show Significant Improvement at One Year IRVINE, CA / ACCESSWIRE / October 21, 2020 / Hancock Jaffe Laboratories, Inc. (Nasdaq:HJLI, HJLIW), a developer of medical devices that restore cardiac and vascular health, announced today that the ninth VenoValve patient ...
Message Board Posts | Hancock Jaffe Laboratories Inc. Warrants (NASDAQ:HJLIW)
Subject | By | Source | When |
---|---|---|---|
No posts yet. |
News, Short Squeeze, Breakout and More Instantly...
Hancock Jaffe Laboratories Inc. Warrants Company Name:
HJLIW Stock Symbol:
NASDAQ Market:
Patient Shows Significant Improvement at One Year IRVINE, CA / ACCESSWIRE / December 1, 2020 / Hancock Jaffe Laboratories, Inc. (NASDAQ:HJLI, HJLIW), a developer of medical devices that restore cardiac and vascular health, announced today that the tenth VenoValve patient in HJLI's fi...
Patient Continues to Show Significant Improvement at One Year IRVINE, CA / ACCESSWIRE / October 21, 2020 / Hancock Jaffe Laboratories, Inc. (Nasdaq:HJLI, HJLIW), a developer of medical devices that restore cardiac and vascular health, announced today that the ninth VenoValve patient ...
Companies Sign Non-Binding Letter of Intent to Merge IRVINE, CA / ACCESSWIRE / June 1, 2020 / Hancock Jaffe Laboratories, Inc. (NASDAQ:HJLI), a developer of medical devices that restore cardiac and vascular health, today announced that the Company has signed a non-binding letter of in...